Skip to main content
Caplight Logo









Promip

Promip

Private
PiracicabaHealthcare & Life Scienceshttps://promip.agr.br/

Last Round

Growth Equity

Jan 7, 2025

Est. Valuation

$11.52M

Total Funding Raised

$5M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Promip operates in Healthcare & Life Sciences and is based in Piracicaba. Its latest recorded funding round was a Growth Equity round in January 2025.

Promip is an agricultural biotechnology company that develops, produces, and commercializes biological products for integrated pest management.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Promip Comparables

Compare Promip with similar companies based on industry and business-model similarity.

Promip comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
BioBee Sde Eliyahu
78%
Simbiose Agro
77%
Bioline AgroSciences
76%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Promip Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Growth EquityJan 7, 2025
Series ASep 8, 2014
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Promip Investors

Notable investors and investment history

Promip investors
InvestorRounds
SP VenturesSeries A
Angra PartnersGrowth Equity

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 21, 2026

    Monthly visitors grew 50% MoM.

  • Jul 28, 2026

    Monthly visitors increased 89% MoM.

Book a demo to see all signals

For institutional investors. Book with your work email.

Promip Filings

Explore SEC and related filing metadata, where available.

Promip filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Promip's valuation, stock price, and market status.

Is Promip a public or private company?

Promip is a private company.

What is the current stock price of Promip?

Promip is a private company, so its shares have no public market price. Caplight tracks Promip's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Promip worth (valuation)?

Promip's valuation is estimated at $11.5M based on funding round data.

Can I buy Promip stock?

Promip shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Promip's last funding round?

Promip's most recent funding round was Growth Equity on January 7, 2025.

Who are the main investors in Promip?

Key investors in Promip include SP Ventures, Angra Partners.

Will Promip IPO soon?

No public IPO plans have been announced for Promip.

How can I track Promip secondary market activity?

Caplight tracks bids, offers, and trades in Promip's shares on secondary markets.

Firmographic Details

HeadquartersPiracicaba
Employee Range65
Year Founded2006
Last FundingJan 7, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?